EVH
Evolent Health, Inc.
Price Chart
Latest Quote
$4.31
-0.18 (-4.11%)
Current Price
| Previous Close | $4.49 |
| Open | $4.44 |
| Day High | $4.53 |
| Day Low | $4.30 |
| Volume | 265,914 |
Stock Information
| Shares Outstanding | 112.48M |
| Total Debt | $985.43M |
| Cash Equivalents | $142.03M |
| Revenue | $1.89B |
| Net Income | $-533.78M |
| Sector | Healthcare |
| Industry | Health Information Services |
| Market Cap | $484.26M |
| EPS (TTM) | $-4.68 |
| Exchange | NYQ |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $1.35B |
| Sales | $1.89B |
| Income | $-533.78M |
| Book/sh | $3.52 |
| Cash/sh | $1.26 |
| Employees | 4K |
Financial Ratios
| Quick Ratio | 1.20 |
| Current Ratio | 1.32 |
| Debt/Eq | 248.60 |
Returns & Margins
| ROA | -0.45% |
| ROE | -65.11% |
| Gross Margin | 20.18% |
| Operating Margin | -2.04% |
| Profit Margin | -26.29% |
Ownership
| Insider Ownership | 2.49% |
| Institutional Ownership | 100.95% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 11.19 |
| PEG | 1.93 |
| P/S | 0.26 |
| P/B | 1.22 |
Analyst Data
| Recommendation | buy |
| Target Price | $5.88 |
Technical Indicators
| SMA20 | $4.30 |
| SMA50 | $3.83 |
| SMA200 | $4.63 |
| RSI | 52.48 |
| ATR | 0.3344 |
| Shares Float | 94.02M |
| Short Float | 13.30% |
| Short Ratio | 5.42 |
| Volatility | 0.83 |
| Rel Volume | 0.11 |
Performance History
| Week | -10.31% |
| Month | +11.54% |
| Quarter | +66.87% |
| 6 Months | +6.57% |
| YTD | +10.68% |
| Year | -50.23% |
| 3 Years | -85.65% |
| 5 Years | -77.88% |
| 10 Years | -75.19% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-22 | $4.31 | 265,914 |
| 2026-06-18 | $4.49 | 2,840,300 |
| 2026-06-17 | $4.67 | 1,912,000 |
| 2026-06-16 | $4.70 | 2,762,600 |
| 2026-06-15 | $4.70 | 2,691,600 |
| 2026-06-12 | $4.80 | 2,109,700 |
| 2026-06-11 | $4.58 | 1,707,900 |
| 2026-06-10 | $4.47 | 1,900,800 |
| 2026-06-09 | $4.72 | 2,958,500 |
| 2026-06-08 | $4.66 | 3,510,700 |
| 2026-06-05 | $4.22 | 2,058,800 |
| 2026-06-04 | $4.38 | 3,086,300 |
| 2026-06-03 | $3.78 | 3,082,600 |
| 2026-06-02 | $3.96 | 2,333,400 |
| 2026-06-01 | $4.17 | 2,869,900 |
| 2026-05-29 | $3.95 | 3,040,000 |
| 2026-05-28 | $3.90 | 2,260,500 |
| 2026-05-27 | $3.72 | 2,042,000 |
| 2026-05-26 | $3.83 | 1,553,600 |
| 2026-05-22 | $3.95 | 2,200,200 |
About Evolent Health, Inc.
Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform for health plan administration and management. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides Machinify Auth Intelligence, an artificial intelligence tool to aid nurses and physicians in completing clinical review of prior authorization requests. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.
đ° Latest News
Q1 Earnings Outperformers: Evolent Health (NYSE:EVH) And The Rest Of The Healthcare Technology for Providers Stocks
StockStory âĸ 2026-06-12T20:05:20Z
Veeva's Falcon and Vault AI: When Could AI Become a Revenue Driver?
Zacks âĸ 2026-06-09T16:20:00Z
Is Privia Health Stock a Buy After Hedge Fund Rubicon Founders Added Over 175,000 Shares to Its Position?
Motley Fool âĸ 2026-05-30T20:27:35Z
3 Healthcare Stocks We Approach with Caution
StockStory âĸ 2026-05-29T17:28:38Z
3 Reasons EVH is Risky and 1 Stock to Buy Instead
StockStory âĸ 2026-05-27T16:01:24Z
3 Russell 2000 Stocks Weâre Skeptical Of
StockStory âĸ 2026-05-23T16:28:55Z
Agentic AI Powers U.S. Healthcare Stocks
24/7 Wall St. âĸ 2026-05-18T00:19:15Z
Rosarium Health Raises $6M In Seed Funding Round To Provide Reliable And Faster In-Home Care For Aging Populations
AfroTech âĸ 2026-05-12T14:41:27Z
3 Small-Cap Stocks We Find Risky
StockStory âĸ 2026-05-12T13:08:55Z
Evolent Health Q1 Earnings Call Highlights
MarketBeat âĸ 2026-05-10T09:12:28Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $1,476,346,000 | $2,187,388,000 | $1,503,426,000 | $1,035,429,000 |
| Cost Of Revenue | $1,476,346,000 | $2,187,388,000 | $1,503,426,000 | $1,035,429,000 |
| Total Revenue | $1,876,229,000 | $2,554,741,000 | $1,963,896,000 | $1,352,013,000 |
| Operating Revenue | $1,876,229,000 | $2,554,741,000 | $1,963,896,000 | $1,352,013,000 |
| Expenses | ||||
| Interest Expense | $57,471,000 | $24,722,000 | $54,205,000 | $15,572,000 |
| Total Expenses | $1,896,063,000 | $2,568,808,000 | $1,984,951,000 | $1,371,893,000 |
| Other Income Expense | $-461,521,000 | $-29,791,000 | $-132,401,000 | $-27,994,000 |
| Other Non Operating Income Expenses | $-15,555,000 | $68,000 | $-62,525,000 | $-45,893,000 |
| Net Non Operating Interest Income Expense | $-53,281,000 | $-19,178,000 | $-48,949,000 | $-14,203,000 |
| Interest Expense Non Operating | $57,471,000 | $24,722,000 | $54,205,000 | $15,572,000 |
| Operating Expense | $419,717,000 | $381,420,000 | $481,525,000 | $336,464,000 |
| General And Administrative Expense | - | - | - | - |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-534,510,000 | $-61,623,000 | $-113,040,000 | $-18,701,000 |
| Net Interest Income | $-53,281,000 | $-19,178,000 | $-48,949,000 | $-14,203,000 |
| Interest Income | $4,190,000 | $5,544,000 | $5,256,000 | $1,369,000 |
| Normalized Income | $-88,179,000 | $-35,786,196 | $-56,818,860 | $-29,231,700 |
| Net Income From Continuing And Discontinued Operation | $-534,510,000 | $-61,623,000 | $-113,040,000 | $-19,164,000 |
| Total Operating Income As Reported | $-410,138,000 | $-40,485,000 | $-71,211,000 | $3,642,000 |
| Net Income Common Stockholders | $-579,401,000 | $-93,454,000 | $-142,260,000 | $-19,164,000 |
| Net Income | $-534,510,000 | $-61,623,000 | $-113,040,000 | $-19,164,000 |
| Net Income Including Noncontrolling Interests | $-534,510,000 | $-61,623,000 | $-113,040,000 | $-19,164,000 |
| Net Income Continuous Operations | $-534,510,000 | $-61,623,000 | $-113,040,000 | $-18,701,000 |
| Pretax Income | $-534,636,000 | $-63,036,000 | $-202,405,000 | $-62,077,000 |
| Special Income Charges | $-393,787,000 | $-26,418,000 | $-71,166,000 | $13,330,000 |
| Earnings From Equity Interest | $365,000 | $-3,441,000 | $1,290,000 | $4,569,000 |
| Interest Income Non Operating | $4,190,000 | $5,544,000 | $5,256,000 | $1,369,000 |
| Operating Income | $-19,834,000 | $-14,067,000 | $-21,055,000 | $-19,880,000 |
| Depreciation Amortization Depletion Income Statement | $115,851,000 | $118,370,000 | $123,415,000 | $67,195,000 |
| Depreciation And Amortization In Income Statement | $115,851,000 | $118,370,000 | $123,415,000 | $67,195,000 |
| Gross Profit | $399,883,000 | $367,353,000 | $460,470,000 | $316,584,000 |
| Net Income Discontinuous Operations | - | $0 | $0 | $-463,000 |
| Per Share | ||||
| Diluted EPS | $-5.07 | $-0.81 | $-1.28 | $-0.20 |
| Basic EPS | $-5.07 | $-0.81 | $-1.28 | $-0.20 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $-581,196 | $-14,944,860 | $2,799,300 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $85,017,000 | $106,474,000 | $46,381,000 | $7,360,000 |
| Total Unusual Items | $-446,331,000 | $-26,418,000 | $-71,166,000 | $13,330,000 |
| Total Unusual Items Excluding Goodwill | $-446,331,000 | $-26,418,000 | $-71,166,000 | $13,330,000 |
| Reconciled Depreciation | $115,851,000 | $118,370,000 | $123,415,000 | $67,195,000 |
| EBITDA (Bullshit earnings) | $-361,314,000 | $80,056,000 | $-24,785,000 | $20,690,000 |
| EBIT | $-477,165,000 | $-38,314,000 | $-148,200,000 | $-46,505,000 |
| Diluted Average Shares | $114,208,000 | $114,682,000 | $111,251,000 | $93,699,000 |
| Basic Average Shares | $114,208,000 | $114,682,000 | $111,251,000 | $93,699,000 |
| Diluted NI Availto Com Stockholders | $-579,401,000 | $-93,454,000 | $-142,260,000 | $-19,164,000 |
| Preferred Stock Dividends | $44,891,000 | $31,831,000 | $29,220,000 | - |
| Tax Provision | $-126,000 | $-1,413,000 | $-89,365,000 | $-43,376,000 |
| Gain On Sale Of Ppe | $14,867,000 | $0 | $-8,107,000 | $0 |
| Other Special Charges | $4,159,000 | $18,922,000 | $21,010,000 | $10,192,000 |
| Impairment Of Capital Assets | $398,000,000 | $2,588,000 | $24,065,000 | $0 |
| Restructuring And Mergern Acquisition | $6,495,000 | $4,908,000 | $17,984,000 | $-23,522,000 |
| Gain On Sale Of Security | $-52,544,000 | - | - | - |
| Selling General And Administration | $303,866,000 | $263,050,000 | $358,110,000 | $269,269,000 |
| Write Off | - | - | - | $0 |
| Minority Interests | - | - | - | - |
| Other Gand A | - | - | - | - |
Fetched: 2026-06-15
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-864,225,000 | $-816,217,000 | $-800,850,000 | $-306,141,000 |
| Total Assets | $1,899,236,000 | $2,544,411,000 | $2,680,308,000 | $1,817,293,000 |
| Total Non Current Assets | $1,392,864,000 | $1,937,294,000 | $1,996,635,000 | $1,339,239,000 |
| Other Non Current Assets | $5,784,000 | $18,567,000 | $20,892,000 | $14,844,000 |
| Non Current Deferred Assets | $13,537,000 | $13,378,000 | $12,120,000 | $17,461,000 |
| Goodwill And Other Intangible Assets | $1,279,419,000 | $1,817,476,000 | $1,868,551,000 | $1,165,558,000 |
| Other Intangible Assets | $584,937,000 | $680,156,000 | $752,009,000 | $442,784,000 |
| Current Assets | $506,372,000 | $607,117,000 | $683,673,000 | $478,054,000 |
| Other Current Assets | $18,521,000 | $28,938,000 | $30,331,000 | $20,678,000 |
| Restricted Cash | $26,134,000 | $59,295,000 | $13,768,000 | $14,492,000 |
| Receivables | $309,861,000 | $414,681,000 | $446,749,000 | $254,684,000 |
| Accounts Receivable | $309,861,000 | $414,681,000 | $446,749,000 | $254,684,000 |
| Allowance For Doubtful Accounts Receivable | $-20,720,000 | $-15,368,000 | $-16,361,000 | $-10,180,000 |
| Gross Accounts Receivable | $330,581,000 | $430,049,000 | $463,110,000 | $264,864,000 |
| Cash Cash Equivalents And Short Term Investments | $151,856,000 | $104,203,000 | $192,825,000 | $188,200,000 |
| Cash And Cash Equivalents | $151,856,000 | $104,203,000 | $192,825,000 | $188,200,000 |
| Non Current Prepaid Assets | - | - | - | - |
| Assets Held For Sale Current | - | - | - | - |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Net Debt | $818,681,000 | $557,784,000 | $404,224,000 | $224,786,000 |
| Total Debt | $989,698,000 | $713,673,000 | $644,796,000 | $476,118,000 |
| Long Term Debt And Capital Lease Obligation | $974,355,000 | $515,489,000 | $635,058,000 | $468,996,000 |
| Long Term Debt | $970,537,000 | $490,520,000 | $597,049,000 | $412,986,000 |
| Current Debt And Capital Lease Obligation | $15,343,000 | $198,184,000 | $9,738,000 | $7,122,000 |
| Current Debt | - | $171,467,000 | - | - |
| Other Current Borrowings | - | $171,467,000 | - | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $1,484,042,000 | $1,543,152,000 | $1,612,607,000 | $957,876,000 |
| Total Non Current Liabilities Net Minority Interest | $1,098,782,000 | $827,651,000 | $938,365,000 | $524,434,000 |
| Other Non Current Liabilities | $8,012,000 | $2,984,000 | $3,637,000 | $4,744,000 |
| Non Current Deferred Liabilities | $116,415,000 | $119,005,000 | $121,243,000 | $50,694,000 |
| Non Current Deferred Taxes Liabilities | $116,415,000 | $119,005,000 | $121,243,000 | $50,694,000 |
| Current Liabilities | $385,260,000 | $715,501,000 | $674,242,000 | $433,442,000 |
| Current Deferred Liabilities | $1,203,000 | $2,507,000 | $5,976,000 | $5,758,000 |
| Payables And Accrued Expenses | $125,531,000 | $162,386,000 | $198,095,000 | $168,372,000 |
| Payables | $59,776,000 | $96,025,000 | $48,246,000 | $57,174,000 |
| Accounts Payable | $59,776,000 | $96,025,000 | $48,246,000 | $57,174,000 |
| Tradeand Other Payables Non Current | - | - | - | $45,950,000 |
| Liabilities Heldfor Sale Non Current | - | - | - | - |
| Equity | ||||
| Common Stock Equity | $415,194,000 | $1,001,259,000 | $1,067,701,000 | $859,417,000 |
| Total Equity Gross Minority Interest | $415,194,000 | $1,001,259,000 | $1,067,701,000 | $859,417,000 |
| Stockholders Equity | $415,194,000 | $1,001,259,000 | $1,067,701,000 | $859,417,000 |
| Gains Losses Not Affecting Retained Earnings | $-2,624,000 | $-1,753,000 | $-1,257,000 | $-1,178,000 |
| Other Equity Adjustments | $-2,624,000 | $-1,753,000 | $-1,257,000 | $-1,178,000 |
| Retained Earnings | $-1,315,327,000 | $-780,817,000 | $-719,194,000 | $-606,154,000 |
| Long Term Equity Investment | $8,966,000 | $8,588,000 | $4,895,000 | $4,475,000 |
| Preferred Securities Outside Stock Equity | - | $190,173,000 | $178,427,000 | $0 |
| Other | ||||
| Treasury Shares Number | $5,971,712 | $1,537,582 | $1,537,582 | $1,537,582 |
| Ordinary Shares Number | $111,632,094 | $115,038,191 | $113,887,251 | $99,962,976 |
| Share Issued | $117,603,806 | $116,575,773 | $115,424,833 | $101,500,558 |
| Tangible Book Value | $-864,225,000 | $-816,217,000 | $-800,850,000 | $-306,141,000 |
| Invested Capital | $1,385,731,000 | $1,663,246,000 | $1,664,750,000 | $1,272,403,000 |
| Working Capital | $121,112,000 | $-108,384,000 | $9,431,000 | $44,612,000 |
| Capital Lease Obligations | $19,161,000 | $51,686,000 | $47,747,000 | $63,132,000 |
| Total Capitalization | $1,385,731,000 | $1,491,779,000 | $1,664,750,000 | $1,272,403,000 |
| Treasury Stock | $61,429,000 | $21,123,000 | $21,123,000 | $21,123,000 |
| Additional Paid In Capital | $1,793,398,000 | $1,803,786,000 | $1,808,121,000 | $1,486,857,000 |
| Capital Stock | $1,176,000 | $1,166,000 | $1,154,000 | $1,015,000 |
| Common Stock | $1,176,000 | $1,166,000 | $1,154,000 | $1,015,000 |
| Preferred Stock | $0 | - | - | - |
| Long Term Capital Lease Obligation | $3,818,000 | $24,969,000 | $38,009,000 | $56,010,000 |
| Current Deferred Revenue | $1,203,000 | $2,507,000 | $5,976,000 | $5,758,000 |
| Current Capital Lease Obligation | $15,343,000 | $26,717,000 | $9,738,000 | $7,122,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $50,987,000 | $33,719,000 | $56,385,000 | $52,460,000 |
| Current Provisions | $192,196,000 | $318,705,000 | $404,048,000 | $199,730,000 |
| Current Accrued Expenses | $65,755,000 | $66,361,000 | $149,849,000 | $111,198,000 |
| Investments And Advances | $8,966,000 | $8,588,000 | $4,895,000 | $4,475,000 |
| Goodwill | $694,482,000 | $1,137,320,000 | $1,116,542,000 | $722,774,000 |
| Net PPE | $85,158,000 | $79,285,000 | $90,177,000 | $136,901,000 |
| Accumulated Depreciation | $-205,774,000 | $-179,876,000 | $-158,569,000 | $-150,477,000 |
| Gross PPE | $290,932,000 | $259,161,000 | $248,746,000 | $287,378,000 |
| Leases | $1,441,000 | $1,479,000 | $1,052,000 | $14,926,000 |
| Construction In Progress | $268,128,000 | $235,831,000 | $212,913,000 | $189,119,000 |
| Other Properties | $4,373,000 | $6,134,000 | $11,983,000 | $49,027,000 |
| Machinery Furniture Equipment | $16,990,000 | $15,717,000 | $22,798,000 | $34,306,000 |
| Properties | $0 | $0 | $0 | $0 |
Fetched: 2026-06-15
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $4,755,000 | $-6,128,000 | $113,837,000 | $-49,914,000 |
| Operating Activities | ||||
| Operating Cash Flow | $38,843,000 | $18,765,000 | $142,582,000 | $-11,553,000 |
| Cash Flow From Continuing Operating Activities | $38,843,000 | $18,765,000 | $142,582,000 | $-11,553,000 |
| Operating Gains Losses | $40,795,000 | $3,441,000 | $27,827,000 | $5,623,000 |
| Investing Activities | ||||
| Capital Expenditure | $-34,088,000 | $-24,893,000 | $-28,745,000 | $-38,361,000 |
| Investing Cash Flow | $-233,000 | $-62,932,000 | $-415,544,000 | $-259,115,000 |
| Cash From Discontinued Investing Activities | $91,312,000 | $0 | $577,000 | $-9,164,000 |
| Cash Flow From Continuing Investing Activities | $-91,545,000 | $-62,932,000 | $-416,121,000 | $-249,951,000 |
| Net Other Investing Changes | $-57,443,000 | $-30,725,000 | $-388,246,000 | $-217,142,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-39,996,000 | $0 | $0 | - |
| Issuance Of Capital Stock | $0 | $0 | $168,000,000 | $0 |
| Financing Cash Flow | $-35,924,000 | $-565,000 | $281,340,000 | $131,541,000 |
| Cash Flow From Continuing Financing Activities | $-35,924,000 | $-565,000 | $281,340,000 | $131,541,000 |
| Net Other Financing Charges | $-49,864,000 | $-42,517,000 | $-63,679,000 | $-77,767,000 |
| Cash Dividends Paid | $-11,127,000 | $-20,085,000 | $-18,793,000 | $-14,884,000 |
| Preferred Stock Dividend Paid | $-11,127,000 | $-20,085,000 | $-18,793,000 | $0 |
| Net Preferred Stock Issuance | $0 | $0 | $168,000,000 | $0 |
| Preferred Stock Issuance | $0 | $0 | $168,000,000 | $0 |
| Net Common Stock Issuance | $-39,996,000 | $0 | $0 | - |
| Common Stock Dividend Paid | - | $0 | $0 | $-14,884,000 |
| Other | ||||
| Repayment Of Debt | $-342,984,000 | $0 | $-464,201,000 | $0 |
| Issuance Of Debt | $408,047,000 | $58,576,000 | $647,494,000 | $219,740,000 |
| Interest Paid Supplemental Data | $41,160,000 | $20,210,000 | $53,591,000 | $6,269,000 |
| End Cash Position | $180,696,000 | $178,496,000 | $223,457,000 | $215,158,000 |
| Beginning Cash Position | $178,496,000 | $223,457,000 | $215,158,000 | $354,942,000 |
| Effect Of Exchange Rate Changes | $-486,000 | $-229,000 | $-79,000 | $-657,000 |
| Changes In Cash | $2,686,000 | $-44,732,000 | $8,378,000 | $-139,127,000 |
| Proceeds From Stock Option Exercised | $0 | $3,461,000 | $12,519,000 | $4,452,000 |
| Common Stock Payments | $-39,996,000 | $0 | $0 | - |
| Net Issuance Payments Of Debt | $65,063,000 | $58,576,000 | $183,293,000 | $219,740,000 |
| Net Long Term Debt Issuance | $65,063,000 | $58,576,000 | $183,293,000 | $219,740,000 |
| Long Term Debt Payments | $-342,984,000 | $0 | $-464,201,000 | $0 |
| Long Term Debt Issuance | $408,047,000 | $58,576,000 | $647,494,000 | $219,740,000 |
| Net Business Purchase And Sale | $-14,000 | $-7,314,000 | $870,000 | $5,552,000 |
| Sale Of Business | $986,000 | $7,000 | $870,000 | $5,552,000 |
| Purchase Of Business | $-1,000,000 | $-7,321,000 | $0 | $0 |
| Net Intangibles Purchase And Sale | $-34,088,000 | $-24,893,000 | $-28,745,000 | $-38,361,000 |
| Purchase Of Intangibles | $-34,088,000 | $-24,893,000 | $-28,745,000 | $-38,361,000 |
| Change In Working Capital | $-57,384,000 | $-116,557,000 | $21,892,000 | $-106,941,000 |
| Change In Other Working Capital | $-134,766,000 | $-94,868,000 | $198,453,000 | $14,235,000 |
| Change In Other Current Liabilities | $-28,173,000 | $-15,636,000 | $-16,132,000 | $-4,690,000 |
| Change In Payables And Accrued Expense | $26,864,000 | $-42,625,000 | $14,878,000 | $-15,179,000 |
| Change In Accrued Expense | $20,225,000 | $-46,873,000 | $21,601,000 | $-28,344,000 |
| Change In Payable | $6,639,000 | $4,248,000 | $-6,723,000 | $13,165,000 |
| Change In Account Payable | $6,639,000 | $4,248,000 | $-6,723,000 | $13,165,000 |
| Change In Prepaid Assets | $4,988,000 | $4,510,000 | $-10,613,000 | $1,673,000 |
| Change In Receivables | $73,703,000 | $32,062,000 | $-164,694,000 | $-102,980,000 |
| Changes In Account Receivables | $73,703,000 | $32,062,000 | $-164,694,000 | $-102,980,000 |
| Other Non Cash Items | $38,530,000 | $35,616,000 | $49,194,000 | $7,411,000 |
| Stock Based Compensation | $39,739,000 | $39,746,000 | $40,501,000 | $33,981,000 |
| Asset Impairment Charge | $398,000,000 | $2,588,000 | $24,065,000 | $0 |
| Deferred Tax | $-2,178,000 | $-2,816,000 | $-31,272,000 | $342,000 |
| Deferred Income Tax | $-2,178,000 | $-2,816,000 | $-31,272,000 | $342,000 |
| Depreciation Amortization Depletion | $115,851,000 | $118,370,000 | $123,415,000 | $67,195,000 |
| Depreciation And Amortization | $115,851,000 | $118,370,000 | $123,415,000 | $67,195,000 |
| Earnings Losses From Equity Investments | $-365,000 | $3,441,000 | $-1,290,000 | $-4,569,000 |
| Gain Loss On Investment Securities | $52,544,000 | - | - | - |
| Net Income From Continuing Operations | $-534,510,000 | $-61,623,000 | $-113,040,000 | $-19,164,000 |
| Income Tax Paid Supplemental Data | - | $1,386,000 | $4,892,000 | $1,397,000 |
| Net Short Term Debt Issuance | - | - | $-1,514,000 | $0 |
| Net Investment Purchase And Sale | - | - | $0 | $0 |
| Sale Of Investment | - | - | $0 | $0 |
| Purchase Of Investment | - | - | $0 | $0 |
| Short Term Debt Payments | - | - | - | $0 |
| Net PPE Purchase And Sale | - | - | - | $-38,361,000 |
| Purchase Of PPE | - | - | - | $-38,361,000 |
| Change In Other Current Assets | - | - | - | $2,500,000 |
Fetched: 2026-06-15